Introduction
============

Adiponection (ADP) and leptin (LEP) are adipokines with roles in inflammation.

Aim
===

To assess ADP and LEP levels before and after acute abortive treatment in episodic migraineurs (EM).

Methods
=======

Peripheral blood specimens were collected from EM participants before and after acute abortive treatment with sumatriptan/naproxen sodium versus placebo.

Results
=======

A total of 34 participants (17 responders, 17 non-responders) were included. In all participants, for every 1 point increase in the HMW:T-ADP ratio, pain severity increased by 4.11 (CI: 0.44, 7.77; p=0.028). In responders (n=17), crude T-ADP levels were reduced at 30 min (11.49 ± 3.7; p=0.001), 60 min (11.54 ± 3.2; p=0.001) and 120 min (11.39 ± 3.7; p=0.001) after treatment as compared to onset (12.47 ± 3.6). In non-responders (n=17), crude T-ADP levels were unchanged after treatment. After adjustments, T-ADP levels remained decreased 30-120 min after treatment in responders; additionally, HMW-ADP, and the HMW:T-ADP ratio were decreased and LMW-ADP and the LMW:T-ADP ratio (coeff 0.04; CI: 0.01, 0.07; p=0.043) were increased 120 min after treatment in responders. In non-responders, the adjusted LMW-ADP (coef -0.45; CI: -0.77, -0.14; p=0.005) and the LMW:T-ADP ratio (coef -0.04; CI: -0.07, -0.01; p=0.018) were decreased at 60 min as well as at 120 min after treatment. Unadjusted and adjusted LEP levels were not modulated by changes in pain severity or treatment response.

Conclusion
==========

Adiponectin, but not leptin, is associated with pain severity and is modulated by treatment response in episodic migraineurs.
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